Catalyst Wire Dossier Catalyst Wire Dossier

Oxaliplatin (Eloxatin)

oxaliplatin · Sanofi
Drug timelines are a Plus or Pro feature.

27 regulatory and trial events tracked for Oxaliplatin (Eloxatin), covering 2010-05-26 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients [Phase 2]

See pricing